Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Robert Desantis sold 1,498 shares of the company’s stock in a transaction dated Friday, April 26th. The shares were sold at an average price of $369.92, for a total transaction of $554,140.16. Following the completion of the sale, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at $2,037,149.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Robert Desantis also recently made the following trade(s):
- On Monday, April 29th, Robert Desantis sold 376 shares of Intuitive Surgical stock. The shares were sold at an average price of $375.39, for a total transaction of $141,146.64.
- On Monday, March 11th, Robert Desantis sold 329 shares of Intuitive Surgical stock. The stock was sold at an average price of $390.16, for a total transaction of $128,362.64.
- On Friday, March 8th, Robert Desantis sold 20,296 shares of Intuitive Surgical stock. The stock was sold at an average price of $393.80, for a total transaction of $7,992,564.80.
Intuitive Surgical Price Performance
ISRG stock opened at $377.65 on Friday. The company’s 50 day simple moving average is $385.56 and its 200-day simple moving average is $348.56. The firm has a market capitalization of $133.96 billion, a PE ratio of 68.17, a P/E/G ratio of 4.79 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $403.76.
Analyst Ratings Changes
ISRG has been the subject of several analyst reports. Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. BTIG Research increased their price target on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Raymond James increased their price target on shares of Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Mizuho increased their price target on shares of Intuitive Surgical from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Thursday, January 25th. Finally, Citigroup upped their target price on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Five research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $396.17.
Read Our Latest Analysis on ISRG
Hedge Funds Weigh In On Intuitive Surgical
Several institutional investors and hedge funds have recently modified their holdings of the company. Central Pacific Bank Trust Division purchased a new position in shares of Intuitive Surgical during the first quarter valued at approximately $2,695,000. Whittier Trust Co. of Nevada Inc. lifted its stake in shares of Intuitive Surgical by 6.1% during the first quarter. Whittier Trust Co. of Nevada Inc. now owns 8,868 shares of the medical equipment provider’s stock valued at $3,539,000 after buying an additional 509 shares during the period. Patron Partners LLC lifted its stake in shares of Intuitive Surgical by 3.9% during the first quarter. Patron Partners LLC now owns 1,776 shares of the medical equipment provider’s stock valued at $709,000 after buying an additional 67 shares during the period. Whittier Trust Co. lifted its stake in shares of Intuitive Surgical by 2.6% during the first quarter. Whittier Trust Co. now owns 9,166 shares of the medical equipment provider’s stock valued at $3,658,000 after buying an additional 229 shares during the period. Finally, Diversified LLC lifted its stake in shares of Intuitive Surgical by 6.4% during the first quarter. Diversified LLC now owns 695 shares of the medical equipment provider’s stock valued at $277,000 after buying an additional 42 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Dividend Capture Strategy: What You Need to Know
- Meta Stock: 3 Reasons This Stumble Is a Golden Buying Opportunity
- With Risk Tolerance, One Size Does Not Fit All
- 3 Staples Stocks to Cushion Lower Consumer Sentiment
- Pros And Cons Of Monthly Dividend Stocks
- Zillow’s Earnings Dip: An Opportunity for Visionaries
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.